Table:
Male, n (%)	Female, n (%)	Total, n (%)
Pathological stage
I	8 (13.6)	51 (84.4)	59 (61.5)
II	2 (40.0)	3 (60.0)	5 (5.2)
III	2 (11.0)	16 (88.9)	18 (18.8)
IV	2 (14.3)	12 (85.7)	14 (14.6)
Total	14 (14.6)	82 (85.4)	96 (100)
Histology
Adenocarcinoma	11 (12.2)	79 (87.8)	90 (93.8)
Squamous cell carcinoma	3 (75.0)	1 (25.0)	4 (4.2)
Small cell carcinoma	0 (0.0)	0 (0.0)	0 (0.0)
Others	0 (0.0)	2 (100)	2 (2.1)
EGFR mutation status
Positive	5 (8.8)	52 (91.2)	57 (59.4)
Exon 19	1 (4.3)	22 (95.7)	23 (24.0)
L858R	3 (12.0)	22 (88.0)	25 (26.0)
Others	1 (11.1)	8 (88.9)	9 (9.4)
Negative	9 (23.1)	30 (76.9)	39 (40.6)
HPV genotyping status
Positive	0 (0.0)	1 (100.0)	1 (1.0)
Negative	14 (14.7)	81 (85.3)	95 (99.0)

What are the following image content in markdown style: |  | Male, n (%) | Female, n (%) | Total, n (%) | 
 | --- | --- | --- | --- | 
 | <COLSPAN=4> Pathological stage | 
 | I | 8 (13.6) | 51 (84.4) | 59 (61.5) | 
 | II | 2 (40.0) | 3 (60.0) | 5 (5.2) | 
 | III | 2 (11.0) | 16 (88.9) | 18 (18.8) | 
 | IV | 2 (14.3) | 12 (85.7) | 14 (14.6) | 
 | Total | 14 (14.6) | 82 (85.4) | 96 (100) | 
 | <COLSPAN=4> Histology | 
 | Adenocarcinoma | 11 (12.2) | 79 (87.8) | 90 (93.8) | 
 | Squamous cell carcinoma | 3 (75.0) | 1 (25.0) | 4 (4.2) | 
 | Small cell carcinoma | 0 (0.0) | 0 (0.0) | 0 (0.0) | 
 | Others | 0 (0.0) | 2 (100) | 2 (2.1) | 
 | <COLSPAN=4> EGFR mutation status | 
 | Positive | 5 (8.8) | 52 (91.2) | 57 (59.4) | 
 | Exon 19 | 1 (4.3) | 22 (95.7) | 23 (24.0) | 
 | L858R | 3 (12.0) | 22 (88.0) | 25 (26.0) | 
 | Others | 1 (11.1) | 8 (88.9) | 9 (9.4) | 
 |

Negative | 9 (23.1) | 30 (76.9) | 39 (40.6) | 
 | <COLSPAN=4> HPV genotyping status | 
 | Positive | 0 (0.0) | 1 (100.0) | 1 (1.0) | 
 | Negative | 14 (14.7) | 81 (85.3) | 95 (99.0) |